BioCardia, Inc.BCDA
Price (close)
$1.05
Market cap
$15.7M
P/E
—
Revenue (TTM)
$0
Net income
-$7.3M
Dividend yield
—
1-year total return
-25.5%
Net margin
—
Revenue growth
—
Debt / equity
—
What BioCardia, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $145,000 | $1.0M | $1.4M | $477,000 | $58,000 | $0 |
| Net income | -$15.0M | -$12.6M | -$11.9M | -$11.6M | -$7.9M | -$8.2M |
| Free cash flow | -$12.4M | -$10.5M | -$10.6M | -$10.0M | -$7.9M | -$7.4M |
More on BCDA.
- BioCardia, Inc. summary
- BioCardia, Inc. financial statements
- BioCardia, Inc. key metrics
- BioCardia, Inc. health scores and style box
- BioCardia, Inc. earnings
- BioCardia, Inc. dividends
- BioCardia, Inc. valuation
- BioCardia, Inc. ownership and insiders
- BioCardia, Inc. peers
Figures from BioCardia, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.